Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
3SBio
AddedFeb 17, 2024
UpdatedJun 28, 2026
3SBio

3SBio

Public

Sunshine Guojian: A Shenyang-based biotech firm, manufacturing vaccines, antibody drugs, and more for China.

HQ
Shenyang, Liaoning, CN
Founded
1993
Overview
Compare
Fundraising
Employees

3SBio, based in Shenyang, Liaoning Province, China, focuses on developing and manufacturing biotechnology products, including vaccines, toxoids, and antibody drugs. The company aims to address critical healthcare needs within China, leveraging advanced biotechnological methods to produce effective medical solutions.

3SBio has made significant strides in the biotech industry, contributing to the healthcare sector with its innovative products. The company markets its offerings throughout China, impacting public health positively by providing essential vaccines and antibody treatments.

3SBio - Similar Companies

Innovent Biologics logo

Innovent Biologics

Sinovac Biotech logo

Sinovac Biotech

Livzon Mabpharm logo

Livzon Mabpharm

Sino Biopharmaceutical logo

Sino Biopharmaceutical

SK Bioscience logo

SK Bioscience

skbioscience.co.kr

Salubris Bio logo

Salubris Bio

salubrisbio.com

Synbody Biotechnology logo

Synbody Biotechnology

Zebra Biologics logo

Zebra Biologics

iBio logo

iBio

ibioinc.com

SAB Biotherapeutics logo

SAB Biotherapeutics

sab.bio

Zai Lab logo

Zai Lab

zailaboratory.com

Shanghai Junshi Biosciences Co logo

Shanghai Junshi Biosciences Co

junshipharma.com

Chengdu Kanghua Biological Products Co. logo

Chengdu Kanghua Biological Products Co.

Kyntra Bio logo

Kyntra Bio

fibrogen.com

AltruBio logo

AltruBio

3SBio - Quick Facts

Who are 3SBio's competitors?

Companies similar to 3SBio include Innovent Biologics, Sinovac Biotech, Livzon Mabpharm and Sino Biopharmaceutical.

When was 3SBio founded?

3SBio was founded in 1993.

Where is 3SBio's headquarters located?

3SBio's headquarters is located in Shenyang, Liaoning, CN.

When was 3SBio's last funding round?

3SBio's most recent funding round was for $15M (USD) in December 2019.

How much has 3SBio raised to-date?

As of Dec 12, 2019, 3SBio has raised a total of $15M (USD).

How many employees does 3SBio have?

3SBio has 5,311 employees as of Feb 12, 2024.

3SBio - Classification

Ownership
  • Private
Technology
  • Biotech
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Antibody Drugs
  • Vaccines
Tags
  • Distribution
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research